Stay updated on Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.

Latest updates to the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change reflects a behind-the-scenes update rather than a modification to study data or descriptions.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer indicates an updated ClinicalTrials.gov software/site revision number, moving from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck and Small cell lung carcinoma to the list of conditions. Added Genetic and Rare Diseases Information Center as a related resources reference.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Naples, Italy (80131) as a study site and updated the city name from Napoli to Naples.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check102 days agoChange DetectedThe page shows a minor site version update with Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.